| 0.2663 0.042 (18.72%) | 09-03 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.31 |
1-year : | 0.37 |
| Resists | First : | 0.27 |
Second : | 0.31 |
| Pivot price | 0.21 |
|||
| Supports | First : | 0.21 |
Second : | 0.17 |
| MAs | MA(5) : | 0.23 |
MA(20) : | 0.21 |
| MA(100) : | 0.26  |
MA(250) : | 0.47 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 71.5 |
D(3) : | 69.3 |
| RSI | RSI(14): 63.1 |
|||
| 52-week | High : | 1.32 | Low : | 0.16 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed above the upper band by 19.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 31.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.27 - 0.27 | 0.27 - 0.27 |
| Low: | 0.22 - 0.22 | 0.22 - 0.22 |
| Close: | 0.26 - 0.27 | 0.27 - 0.27 |
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Thu, 03 Sep 2026
Cosmos Health Q2FY26 Results: Revenue up 28.8% to $18.99M - scanx.trade
Thu, 03 Sep 2026
$8 million debt paid off. Cosmos Health bought back 5.1 million shares. - Stock Titan
Fri, 28 Aug 2026
Cosmos Health Strengthens Balance Sheet and Streamlines - GlobeNewswire
Mon, 24 Aug 2026
Cosmos Health Inc. Projects Over $6 Million in Annual U.S. Revenue for Oliv18™ in 12 to 18 Months - Quiver Quantitative
Tue, 18 Aug 2026
Cosmos Health (NASDAQ: COSM) grows revenue yet flags doubt about its future - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 101 (M) |
| Shares Float | 62 (M) |
| Held by Insiders | 21.6 (%) |
| Held by Institutions | 3.6 (%) |
| Shares Short | 4,080 (K) |
| Shares Short P.Month | 4,740 (K) |
| EPS | -0.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.44 |
| Profit Margin | -33.1 % |
| Operating Margin | -15.5 % |
| Return on Assets (ttm) | -18.5 % |
| Return on Equity (ttm) | -104 % |
| Qtrly Rev. Growth | 28.7 % |
| Gross Profit (p.s.) | 0.07 |
| Sales Per Share | 0.73 |
| EBITDA (p.s.) | -0.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.4 |
| PEG Ratio | 0 |
| Price to Book value | 0.59 |
| Price to Sales | 0.36 |
| Price to Cash Flow | -2.73 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|